Showing results (1311-1320 of 1,327) with videos related to
Sort By:
Pageof 133
Nature Communications|December 9, 2021
Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinomaWei Cheng, Hao-Long Li, Shao-Yan Xi, et al.Science Translational Medicine|February 4, 2021
Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugateFan-En Kong, Guang-Meng Li, Yun-Qiang Tang, et al.Cardiovascular Research|January 15, 2016
TBX5 mutations contribute to early-onset atrial fibrillation in Chinese and CaucasiansJi-Fang Ma, Fan Yang, Saagar N Mahida, et al.Orphanet Journal of Rare Diseases|August 15, 2024
Long-term safety and influence on growth in patients receiving sirolimus: a pooled analysisYang-Yang Wang, Li-Ping Zou, Kai-Feng Xu, et al.BMC Medicine|January 14, 2022
Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinomaBiyuan Luo, Fang Ma, Hao Liu, et al.Journal of Hematology & Oncology|October 18, 2022
Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemiaYa-Fang Ma, Ying Lu, Qian Wu, et al.Translational Neurodegeneration|December 13, 2019
Clinicopathologic characterization and abnormal autophagy of <i>CSF1R</i>-related leukoencephalopathyWo-Tu Tian, Fei-Xia Zhan, Qing Liu, et al.Nature Communications|October 29, 2017
CaMKII-mediated Beclin 1 phosphorylation regulates autophagy that promotes degradation of Id and neuroblastoma cell differentiationXuan Li, Xiao-Qi Wu, Rong Deng, et al.Proceedings of the National Academy of Sciences of the United States of America|March 4, 2020
A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targetsMing Liu, Qian Yan, Yi Sun, et al.The New England Journal of Medicine|October 22, 2025
Sacituzumab Tirumotecan in EGFR-TKI-Resistant, <i>EGFR</i>-Mutated Advanced NSCLCWenfeng Fang, Lin Wu, Xiangjiao Meng, et al.Pageof 133